Reneo Pharmaceuticals gets FDA ODD for REN001 in primary mitochondrial myopathies

Reneo Pharmaceuticals has been granted the orphan drug designation (ODD) for its lead drug candidate REN001 from the US Food and Drug Administration (FDA) for ... Read More